Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms
Lin Ji, Xiao Wang, Yue Li, Wentao Zhao, Xinzhe Du, Yao Gao, Junxia Li, Sha Liu · 2026
Read Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms by Lin Ji, Xiao Wang, Yue Li, Wentao Zhao, Xinzhe Du, Yao Gao, Junxia Li, Sha Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13447861.txt.
Description
Lin Ji and coauthors review a 2026 roundup of oxytocin therapy for dark symptoms of schizophrenia, the drive and outward gaps that resist current drugs. Grounded in a scale-based symptom model, the review traces oxytocin multi-circuit actions on reward, drive, emotion, and motor output.
Oxytocin lifts reward-path handling, fore-brain-striatal drive, fear hub-fore-brain emotion steadiness, and sense-move linking, yet medical results vary widely. Future work should fuse genes, imaging, and conduct to find oxytocin-tuned kinds, tune dosing, and pair drugs with habit therapy toward pinpoint mind care.
Catalog record
| CREATOR | Lin Ji, Xiao Wang, Yue Li, Wentao Zhao, Xinzhe Du, Yao Gao, Junxia Li, Sha Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |